RhumbLine Advisers
ZEPP

RhumbLine Advisers’s Zepp Health ZEPP Stock Holding History

RhumbLine Advisers’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.93K Buy
580
+5
+0.9% +$102 ﹤0.01% 3845
2025
Q4 		$15.5K Buy
575
+497
+637% +$17.7K ﹤0.01% 3797
2025
Q3 		$3.57K Sell
78
-415
-84% -$12.6K ﹤0.01% 3939
2025
Q2 		$1.31K Sell
493
-36
-7% -$92 ﹤0.01% 4022
2025
Q1 		$1.56K Sell
529
-3,457
-87% -$10.3K ﹤0.01% 4001
2024
Q4 		$10.4K Sell
3,986
-3,465
-47% -$10.9K ﹤0.01% 3877
2024
Q3 		$32.4K Sell
7,451
-1
-0% -$3 ﹤0.01% 3752
2024
Q2 		$17.9K Hold
7,452
– – ﹤0.01% 3887
2024
Q1 		$30.4K Sell
7,452
-102
-1% -$526 ﹤0.01% 3708
2023
Q4 		$42.9K Hold
7,554
– – ﹤0.01% 3662
2023
Q3 		$34.7K Buy
7,554
+6,706
+791% +$31.7K ﹤0.01% 3711
2023
Q2 		$3.86K Buy
+848
New +$4.28K ﹤0.01% 4125

Other funds holding ZEPP

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MM
Monolith Management Hong Kong $332M AUM 119.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

RhumbLine Advisers's ZEPP Position: Q1 2026 in Review

RhumbLine Advisers increased its Zepp Health (ZEPP) stake by 0.87% in Q1 2026, buying an estimated $102 and bringing the position to 580 shares worth $6.93K. The position accounts for ﹤0.01% of the portfolio, ranked #3845.

RhumbLine Advisers first reported a position in ZEPP in Q2 2023 and has held it in 12 quarters since. The position peaked at $42.9K in Q4 2023. 32 funds tracked by Wall St. Rank hold ZEPP as of Q1 2026.

  • RhumbLine Advisers held 580 shares of Zepp Health worth $6.93K as of Q1 2026.
  • RhumbLine Advisers bought 5 Zepp Health shares in Q1 2026, an estimated $102.
  • Zepp Health made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3845 holding.
  • RhumbLine Advisers first reported a position in Zepp Health in Q2 2023 and has held it in 12 quarters since.
  • RhumbLine Advisers's Zepp Health position peaked at $42.9K in Q4 2023.
  • 32 funds tracked by Wall St. Rank held Zepp Health as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.